Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation

A. Vidal, C. Wikell, I. Dainty (Mölndal, Sweden)

Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Session: Interventions and other therapeutic approaches in respiratory infections
Session type: Poster Discussion
Number: 250
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Vidal, C. Wikell, I. Dainty (Mölndal, Sweden). Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation. Eur Respir J 2014; 44: Suppl. 58, 250

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute markers of neutrophilic lung infiltration in the non-human primate LPS model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014


Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016


Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


A new model for analysis of chronic bronchial interleukin-8 expression
Source: International Congress 2016 – Airway response to infection
Year: 2016

Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015

A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Chronic pseudomonas aeruginosa airway infection induces peribronchial lymphoid neogenesis in mice
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013

Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015


Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015